首页 > 最新文献

中华男科学杂志最新文献

英文 中文
[Physical intervention combined with medical nutritional weight loss for the treatment of short penis in obese children]. 【物理干预联合药物营养减肥治疗肥胖儿童短阴茎】。
Q4 Medicine Pub Date : 2025-04-01
Yi-Na Ma, Wan-Ting Pu, Turdi Nafisa, Kai-Fang Liu, Jia Li

Objective: To investigate the clinical effect of physical intervention combined with medical nutritional weight loss (PI+MNWL) in the treatment of short penis in obese children.

Methods: One hundred and twenty obese children with a short penis were included and equally divided into three groups: PI+MNWL, MNWL, and self-guided diet, who underwent PI+MNWL, MNWL intervention under the supervision of professional nutritionists in the hospital, or self-guided diet intervention at home, respectively, all for 30 days. We measured the penile parameters, including stretched penile length (SPL), flaccid penile length (FPL) and penile diameter (PD), of the children before and after treatment, and compared them among the three groups.

Results: After intervention, the body weight of the children was significantly decreased in all the three groups (27.1-94.1[53.59±11.88] kg vs 23.0-85.1[49.01±11.61] kg, P < 0.05). The weight of children in 3 groups decreased to different degrees, and the difference was statistically significant (P < 0.05). MNWL was found remarkably more effective than self-guided weight loss in reducing the body weight of the children (P < 0.05). Based on weight loss achieved through medical nutrition combined with physical intervention, the FPL in the PI+MNWL group increased from (1.93 ± 0.76) cm before treatment to (3.41 ± 1.41) cm after one course of comprehensive treatment, with a statistically significant difference (P < 0.05). Similarly, SPL increased from (3.75 ± 0.76) cm before treatment to (4.98 ± 0.64) cm, and PD increased from (1.32 ± 0.21) cm before treatment to (1.61 ± 0.66) cm, both showing statistically significant differences (P < 0.05). In the MNWL group , FPL increased from (2.01 ± 0.81) cm to (2.77 ± 0.84) cm after one course of treatment, with a statistically significant difference (P < 0.05). Additionally, SPL increased from (4.03 ± 0.84) cm before treatment to (4.40 ± 0.76) cm, also demonstrating statistical significance (P < 0.05), while PD increased from (1.37 ± 0.21) cm before treatment to (1.42 ± 0.22) cm, with statistical significance (P < 0.05). FPL and SPL increased significantly in the PI+MNWL group compared to the MNWL group (P < 0.05, P < 0.01). However, there was no significant difference in PD between the two groups following the intervention (P > 0.05).

Conclusion: MNWL is more effective than self-guided diet in controlling the body weight of children, while the combination approach of PI+MNWL is even superior to the management of short penis in obese children, with the advantages of improving the appearance and increasing the exposed length of the penis.

目的:探讨物理干预联合药物营养减重(PI+MNWL)治疗肥胖儿童短阴茎的临床效果。方法:选取120例阴茎过短的肥胖儿童,将其平均分为PI+MNWL组、MNWL组和自我指导饮食组,分别进行PI+MNWL、医院专业营养师指导下的MNWL干预和家庭自我指导饮食干预,疗程均为30 d。测量三组患儿治疗前后的阴茎参数,包括伸展阴茎长度(SPL)、松弛阴茎长度(FPL)和阴茎直径(PD),并进行比较。结果:干预后,三组患儿体重均显著降低(27.1 ~ 94.1[53.59±11.88]kg vs 23.0 ~ 85.1[49.01±11.61]kg, P < 0.05)。3组患儿体重均有不同程度下降,差异均有统计学意义(P < 0.05)。MNWL在减轻儿童体重方面明显优于自我引导减肥(P < 0.05)。在医学营养与物理干预相结合减肥的基础上,PI+MNWL组FPL由治疗前的(1.93±0.76)cm增加到综合治疗1个疗程后的(3.41±1.41)cm,差异有统计学意义(P < 0.05)。SPL由治疗前的(3.75±0.76)cm增至(4.98±0.64)cm, PD由治疗前的(1.32±0.21)cm增至(1.61±0.66)cm,差异均有统计学意义(P < 0.05)。MNWL组1个疗程后FPL由(2.01±0.81)cm增加至(2.77±0.84)cm,差异有统计学意义(P < 0.05)。SPL由治疗前的(4.03±0.84)cm增加至(4.40±0.76)cm,差异均有统计学意义(P < 0.05); PD由治疗前的(1.37±0.21)cm增加至(1.42±0.22)cm,差异均有统计学意义(P < 0.05)。与MNWL组相比,PI+MNWL组的FPL和SPL均显著升高(P < 0.05, P < 0.01)。干预后两组PD无显著差异(P < 0.05)。结论:MNWL在控制儿童体重方面比自我引导饮食更有效,而PI+MNWL联合方式甚至优于肥胖儿童短阴茎的管理,具有改善阴茎外观和增加阴茎暴露长度的优势。
{"title":"[Physical intervention combined with medical nutritional weight loss for the treatment of short penis in obese children].","authors":"Yi-Na Ma, Wan-Ting Pu, Turdi Nafisa, Kai-Fang Liu, Jia Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the clinical effect of physical intervention combined with medical nutritional weight loss (PI+MNWL) in the treatment of short penis in obese children.</p><p><strong>Methods: </strong>One hundred and twenty obese children with a short penis were included and equally divided into three groups: PI+MNWL, MNWL, and self-guided diet, who underwent PI+MNWL, MNWL intervention under the supervision of professional nutritionists in the hospital, or self-guided diet intervention at home, respectively, all for 30 days. We measured the penile parameters, including stretched penile length (SPL), flaccid penile length (FPL) and penile diameter (PD), of the children before and after treatment, and compared them among the three groups.</p><p><strong>Results: </strong>After intervention, the body weight of the children was significantly decreased in all the three groups (27.1-94.1[53.59±11.88] kg vs 23.0-85.1[49.01±11.61] kg, P < 0.05). The weight of children in 3 groups decreased to different degrees, and the difference was statistically significant (P < 0.05). MNWL was found remarkably more effective than self-guided weight loss in reducing the body weight of the children (P < 0.05). Based on weight loss achieved through medical nutrition combined with physical intervention, the FPL in the PI+MNWL group increased from (1.93 ± 0.76) cm before treatment to (3.41 ± 1.41) cm after one course of comprehensive treatment, with a statistically significant difference (P < 0.05). Similarly, SPL increased from (3.75 ± 0.76) cm before treatment to (4.98 ± 0.64) cm, and PD increased from (1.32 ± 0.21) cm before treatment to (1.61 ± 0.66) cm, both showing statistically significant differences (P < 0.05). In the MNWL group , FPL increased from (2.01 ± 0.81) cm to (2.77 ± 0.84) cm after one course of treatment, with a statistically significant difference (P < 0.05). Additionally, SPL increased from (4.03 ± 0.84) cm before treatment to (4.40 ± 0.76) cm, also demonstrating statistical significance (P < 0.05), while PD increased from (1.37 ± 0.21) cm before treatment to (1.42 ± 0.22) cm, with statistical significance (P < 0.05). FPL and SPL increased significantly in the PI+MNWL group compared to the MNWL group (P < 0.05, P < 0.01). However, there was no significant difference in PD between the two groups following the intervention (P > 0.05).</p><p><strong>Conclusion: </strong>MNWL is more effective than self-guided diet in controlling the body weight of children, while the combination approach of PI+MNWL is even superior to the management of short penis in obese children, with the advantages of improving the appearance and increasing the exposed length of the penis.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 4","pages":"300-305"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144817709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress on the correlation of changes in intestinal flora during radiation therapy for prostate cancer]. [前列腺癌放疗期间肠道菌群变化相关性研究进展]。
Q4 Medicine Pub Date : 2025-04-01
Xian Chen, Nuerrula Yiliyaer, Lei Xiao

The intestinal flora is involved in the development of prostate cancer through various mechanisms. And radiotherapy has a significant effect on the composition of the intestinal flora, which triggers clinical symptoms and affects the efficacy of radiotherapy. The mechanisms of the correlation of intestinal flora, prostate cancer and radiotherapy will be described in this article aiming to provide a reference for more effective prevention and prediction of prostate cancer, enhancement of the effectiveness of prostate cancer treatment as well as improvement of patients' quality of life.

肠道菌群通过多种机制参与前列腺癌的发生。而放疗对肠道菌群组成有显著影响,引发临床症状,影响放疗疗效。本文将阐述肠道菌群、前列腺癌与放疗相关的机制,以期为更有效地预防和预测前列腺癌,提高前列腺癌治疗的有效性,提高患者的生活质量提供参考。
{"title":"[Research progress on the correlation of changes in intestinal flora during radiation therapy for prostate cancer].","authors":"Xian Chen, Nuerrula Yiliyaer, Lei Xiao","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The intestinal flora is involved in the development of prostate cancer through various mechanisms. And radiotherapy has a significant effect on the composition of the intestinal flora, which triggers clinical symptoms and affects the efficacy of radiotherapy. The mechanisms of the correlation of intestinal flora, prostate cancer and radiotherapy will be described in this article aiming to provide a reference for more effective prevention and prediction of prostate cancer, enhancement of the effectiveness of prostate cancer treatment as well as improvement of patients' quality of life.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 4","pages":"363-368"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144817710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Efficacy of steam thermal ablation on the treatment of benign prostatic hyperplasia]. 【蒸汽热消融治疗前列腺增生的疗效观察】。
Q4 Medicine Pub Date : 2025-04-01
Ning Shao, Qi-Feng Cao, Jian-Wei Cao, Jian Kang, Qiang Bai, Xin-Gang Cui

Objective: To explore the clinical application of transurethral steam thermal ablation of the prostate as an ultra-minimally invasive treatment of benign prostatic hyperplasia (BPH).

Methods: We treated 18 BPH patients by transurethral steam thermal ablation of the prostate in our hospital, and followed them up for 6-12 months after operation. We obtained the IPSS, maximum urinary flow rate (Qmax), IIEF-5 scores, Male Sexual Health Questionnaire-Ejaculatory Dysfunction-Short Form (MSHQ-EjD-SF) scores and quality of life (QOL) scores from the patients and compared them before and after surgery.

Results: Operations were successfully completed in all the cases, with no intraoperative complications, and all the patients were discharged on the second day after surgery. At the 6-month follow-up after surgery, the Qmax increased from (10.08 ± 2.06) ml/s before surgery to (7.51 ± 3.21) ml/s, the IPSS decreased from 23.72 ± 1.87 to 8.06 ± 1.39, and the QOL score decreased from 5.11 ± 0.58 before surgery to 1.28 ± 0.46. The differences in these indicators were statistically significant (P<0.05). And these is no significant difference in the MSHQ-EjD-SF and IIEF-5 score(P>0.05).

Conclusion: Transurethral steam thermal ablation of the prostate is a safe, effective and almost non-invasive surgical strategy for the treatment of BPH, with a good prospect of clinical application.

目的:探讨经尿道前列腺蒸汽热消融作为一种超微创治疗良性前列腺增生(BPH)的临床应用。方法:对我院18例经尿道前列腺蒸汽热消融治疗的前列腺增生症患者进行术后6 ~ 12个月的随访。获取患者的IPSS、最大尿流率(Qmax)、IIEF-5评分、男性性健康问卷-射精功能障碍短表(MSHQ-EjD-SF)评分和生活质量(QOL)评分,并对术前、术后进行比较。结果:所有病例均顺利完成手术,无术中并发症,术后第2天全部出院。术后随访6个月,Qmax由术前(10.08±2.06)ml/s上升至(7.51±3.21)ml/s, IPSS由23.72±1.87下降至8.06±1.39,生活质量评分由术前5.11±0.58下降至1.28±0.46。各指标差异均有统计学意义(P0.05)。结论:经尿道前列腺蒸汽热消融是一种安全、有效、几乎无创的治疗前列腺增生的手术策略,具有良好的临床应用前景。
{"title":"[Efficacy of steam thermal ablation on the treatment of benign prostatic hyperplasia].","authors":"Ning Shao, Qi-Feng Cao, Jian-Wei Cao, Jian Kang, Qiang Bai, Xin-Gang Cui","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To explore the clinical application of transurethral steam thermal ablation of the prostate as an ultra-minimally invasive treatment of benign prostatic hyperplasia (BPH).</p><p><strong>Methods: </strong>We treated 18 BPH patients by transurethral steam thermal ablation of the prostate in our hospital, and followed them up for 6-12 months after operation. We obtained the IPSS, maximum urinary flow rate (Qmax), IIEF-5 scores, Male Sexual Health Questionnaire-Ejaculatory Dysfunction-Short Form (MSHQ-EjD-SF) scores and quality of life (QOL) scores from the patients and compared them before and after surgery.</p><p><strong>Results: </strong>Operations were successfully completed in all the cases, with no intraoperative complications, and all the patients were discharged on the second day after surgery. At the 6-month follow-up after surgery, the Qmax increased from (10.08 ± 2.06) ml/s before surgery to (7.51 ± 3.21) ml/s, the IPSS decreased from 23.72 ± 1.87 to 8.06 ± 1.39, and the QOL score decreased from 5.11 ± 0.58 before surgery to 1.28 ± 0.46. The differences in these indicators were statistically significant (P<0.05). And these is no significant difference in the MSHQ-EjD-SF and IIEF-5 score(P>0.05).</p><p><strong>Conclusion: </strong>Transurethral steam thermal ablation of the prostate is a safe, effective and almost non-invasive surgical strategy for the treatment of BPH, with a good prospect of clinical application.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 4","pages":"338-340"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144817681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Exploring the causal relationship between leukocyte telomere length and prostatitis, orchitis, and epididymitis based on a two-sample Mendelian randomization]. [基于两样本孟德尔随机化,探讨白细胞端粒长度与前列腺炎、睾丸炎和附睾炎之间的因果关系]。
Q4 Medicine Pub Date : 2025-04-01
Dan-Yang Li, Shun Yu, Bo-Hui Yang, Jun-Bao Zhang, Guo-Chen Yin, Lin-Na Wu, Qin-Zuo Dong, Jin-Long Xu, Shu-Ping Ning, Rong Zhao

Objective: To investigate the genetic causal relationship of leukocyte telomere length (LTL) with prostatitis, orchitis and epididymitis by two-sample Mendelian randomization (MR).

Methods: Using LTL as the exposure factor and prostatitis, orchitis and epididymitis as outcome factors, we mined the Database of Genome-Wide Association Studies (GWAS). Then, we analyzed the causal relationship of LTL with prostatitis, orchitis and epididymitis by Mendelian randomization using inverse variance weighting (IVW) as the main method and weighted median and MR-Egger regression as auxiliary methods, determined the horizontal multiplicity by MR-Egger intercept test, and conducted sensitivity analysis using the leaving-one-out method.

Results: A total of 121 related single nucleotide polymorphisms (SNPs) were identified in this study. IVW showed LTL to be a risk factor for prostatitis (OR = 1.383, 95% CI: 1.044-1.832, P = 0.024), and for orchitis and epididymitis as well (OR = 1.770, 95% CI: 1.275-2.456, P = 0.000 6).

Conclusion: Genetic evidence from Mendelian randomized analysis indicates that shortening of LTL reduces the risk of prostatitis, orchitis and epididymitis.

目的:采用双样本孟德尔随机化(MR)方法探讨白细胞端粒长度(LTL)与前列腺炎、睾丸炎和附睾炎的遗传因果关系。方法:以LTL为暴露因素,前列腺炎、睾丸炎和附睾炎为结局因素,挖掘全基因组关联研究数据库(GWAS)。然后,我们采用孟德尔随机化方法,以逆方差加权(IVW)为主要方法,加权中位数和MR-Egger回归为辅助方法,分析LTL与前列腺炎、睾丸炎和附睾炎的因果关系,采用MR-Egger截距检验确定水平多重度,并采用留一法进行敏感性分析。结果:共鉴定出121个相关的单核苷酸多态性(snp)。IVW显示LTL是前列腺炎(OR = 1.383, 95% CI: 1.044-1.832, P = 0.024)、睾丸炎和附睾炎(OR = 1.770, 95% CI: 1.75 -2.456, P = 0.0006)的危险因素。结论:孟德尔随机分析的遗传学证据表明,LTL缩短可降低前列腺炎、睾丸炎和附睾炎的风险。
{"title":"[Exploring the causal relationship between leukocyte telomere length and prostatitis, orchitis, and epididymitis based on a two-sample Mendelian randomization].","authors":"Dan-Yang Li, Shun Yu, Bo-Hui Yang, Jun-Bao Zhang, Guo-Chen Yin, Lin-Na Wu, Qin-Zuo Dong, Jin-Long Xu, Shu-Ping Ning, Rong Zhao","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the genetic causal relationship of leukocyte telomere length (LTL) with prostatitis, orchitis and epididymitis by two-sample Mendelian randomization (MR).</p><p><strong>Methods: </strong>Using LTL as the exposure factor and prostatitis, orchitis and epididymitis as outcome factors, we mined the Database of Genome-Wide Association Studies (GWAS). Then, we analyzed the causal relationship of LTL with prostatitis, orchitis and epididymitis by Mendelian randomization using inverse variance weighting (IVW) as the main method and weighted median and MR-Egger regression as auxiliary methods, determined the horizontal multiplicity by MR-Egger intercept test, and conducted sensitivity analysis using the leaving-one-out method.</p><p><strong>Results: </strong>A total of 121 related single nucleotide polymorphisms (SNPs) were identified in this study. IVW showed LTL to be a risk factor for prostatitis (OR = 1.383, 95% CI: 1.044-1.832, P = 0.024), and for orchitis and epididymitis as well (OR = 1.770, 95% CI: 1.275-2.456, P = 0.000 6).</p><p><strong>Conclusion: </strong>Genetic evidence from Mendelian randomized analysis indicates that shortening of LTL reduces the risk of prostatitis, orchitis and epididymitis.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 4","pages":"306-312"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144817682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effect of high ligation of spermatic vein on leukocytes in expressed prostate secretion of patients with chronic prostatitis and varicocele]. [精索静脉高位结扎对慢性前列腺炎、精索静脉曲张患者前列腺分泌白细胞表达的影响]。
Q4 Medicine Pub Date : 2025-04-01
Ji-Yang Ding, Peng Zhang, Chun-Hua Niu, Hai-Yong Li, Wen-Zhu Xu, Ying-Chen Zhang, Gang Ma

Objective: To investigate the effect of laparoscopic high ligation of spermatic cord vein in patients with chronic prostatitis and varicocele prostatitis.

Methods: A total of 90 varicocele patients were selected from January 2016 to December 2020, including 33 patients with chronic prostatitis. Changes of white blood cell count, National Institutes of Health chronic prostatitis symptom index (NIH-CPSI) score and serum testosterone level in the expressed prostate secretion (EPS) were observed before and after the operation of laparoscopic high ligation of spermatic vein.

Results: All patients were followed up three months after the surgery. There was no significant difference in the white blood cell counts in EPS, NIH-CPSI score, and serum testosterone level in patients with varicocele-only who underwent high ligation surgery after the operation. However, the white blood cell count in the EPS of patients with chronic prostatitis was lower than that before 3 months of operation ( [12.39±4.23]×109/L vs [21.36±5.05]×109/L). The NIH-CPSI score was significantly lower than that before operation ( [12.71±6.21] vs [26.76±8.43]). And the serum testosterone level was higher than that before operation ([4.34±1.77]ng/ml vs [2.36±1.05]ng/ml).

Conclusion: Laparoscopic high ligation of the spermatic vein in patients with chronic prostatitis and varicocele could effectively reduce the number of white blood cells in the EPS, boost the level of serum testosterone and improves symptoms of chronic prostatitis.

目的:探讨腹腔镜精索静脉高位结扎治疗慢性前列腺炎和精索静脉曲张的效果。方法:选取2016年1月至2020年12月本院收治的精索静脉曲张患者90例,其中慢性前列腺炎患者33例。观察腹腔镜精索静脉高位结扎术前后患者白细胞计数、美国国立卫生研究院慢性前列腺炎症状指数(NIH-CPSI)评分及前列腺分泌表达(EPS)血清睾酮水平的变化。结果:术后3个月随访。单纯精索静脉曲张术后行高位结扎的患者EPS白细胞计数、NIH-CPSI评分、血清睾酮水平差异无统计学意义。但慢性前列腺炎患者EPS白细胞计数较术前降低([12.39±4.23]×109/L vs[21.36±5.05]×109/L)。NIH-CPSI评分明显低于术前([12.71±6.21]vs[26.76±8.43])。血清睾酮水平高于术前([4.34±1.77]ng/ml vs[2.36±1.05]ng/ml)。结论:腹腔镜下精索静脉高位结扎治疗慢性前列腺炎精索静脉曲张患者,可有效降低EPS白细胞数量,提高血清睾酮水平,改善慢性前列腺炎症状。
{"title":"[Effect of high ligation of spermatic vein on leukocytes in expressed prostate secretion of patients with chronic prostatitis and varicocele].","authors":"Ji-Yang Ding, Peng Zhang, Chun-Hua Niu, Hai-Yong Li, Wen-Zhu Xu, Ying-Chen Zhang, Gang Ma","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effect of laparoscopic high ligation of spermatic cord vein in patients with chronic prostatitis and varicocele prostatitis.</p><p><strong>Methods: </strong>A total of 90 varicocele patients were selected from January 2016 to December 2020, including 33 patients with chronic prostatitis. Changes of white blood cell count, National Institutes of Health chronic prostatitis symptom index (NIH-CPSI) score and serum testosterone level in the expressed prostate secretion (EPS) were observed before and after the operation of laparoscopic high ligation of spermatic vein.</p><p><strong>Results: </strong>All patients were followed up three months after the surgery. There was no significant difference in the white blood cell counts in EPS, NIH-CPSI score, and serum testosterone level in patients with varicocele-only who underwent high ligation surgery after the operation. However, the white blood cell count in the EPS of patients with chronic prostatitis was lower than that before 3 months of operation ( [12.39±4.23]×109/L vs [21.36±5.05]×109/L). The NIH-CPSI score was significantly lower than that before operation ( [12.71±6.21] vs [26.76±8.43]). And the serum testosterone level was higher than that before operation ([4.34±1.77]ng/ml vs [2.36±1.05]ng/ml).</p><p><strong>Conclusion: </strong>Laparoscopic high ligation of the spermatic vein in patients with chronic prostatitis and varicocele could effectively reduce the number of white blood cells in the EPS, boost the level of serum testosterone and improves symptoms of chronic prostatitis.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 4","pages":"319-322"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144817679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical efficacy of endocrinotherapy combined with Shenqi Pills on patients with hormone-sensitive prostate cancer]. 【内分泌治疗联合参芪丸治疗激素敏感性前列腺癌的临床疗效观察】。
Q4 Medicine Pub Date : 2025-04-01
Yu-Hong Xie, Gang Yi, Xiao-Wen Yi, Tong-Lin Sun, Qun-Fang Lin, Jun Zhou, Xin-Jun Luo, Fang-Zhi Fu, Biao Wang, Qin-Zheng Wang, Lie Zhang, Yang Yang, Rui-Song Gao, Qing Zhou
<p><strong>Objective: </strong>The aim of this study is to explore the clinical efficacy and safety of endocrinotherapy combined with Shenqi Pills on hormone-sensitive prostate cancer (HSPC).</p><p><strong>Methods: </strong>Eighty patients who were diagnosed with HSPC and renal-yang deficiency at the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine and the Hospital of Traditional Chinese Medicine of Mayang Miao Autonomous County from 1st April 2021 to 30th April 2024 were randomly divided into 2 groups. The patients in the control group were treated with androgen deprivation therapy (ADT). And the patients in treatment group were treated with Shenqi Pills orally on the basis of the control group. The baseline data of the two groups were analyzed. After 36 months of treatment, the differences between the two groups were compared in terms of overall survival (OS), prostate-specific antigen (PSA) level, PSA response rate, Functional Assessment Scale for Prostate Cancer Therapy (FACT-P), Chinese medicine evidence scores, testosterone level and safety.</p><p><strong>Results: </strong>A total of 80 study subjects were included in this study, including 42 cases in the treatment group and 38 cases in the control group. There was no statistical difference in the baseline data between the two groups before treatment (P>0.05). At the end of the observation period, a statistically significant difference in OS was found in the treatment group compared to the control group in the subgroup of patients with a disease duration ranged of 0-6 months (P<0.05). There was no statistically significant difference in PSA levels in the treatment group at 3 months (P>0.05). And the differences in the proportion of PSA50 (98.1% vs 91.4%), PSA90 (92.9% vs 84.6%) and the proportion of decrease in PSA (56.7% vs 33.8%) in the treatment group were found compared to those in the control group after 6 months of tre atment. After 12 months of treatment, the scores of FACT-4 and renal-yang deficiency in the treatment group were (95.28±7.93) and (15.73±5.70) respectively, compared to the scores in the control group ([85.46±10.12] and [18.20±4.27] (P<0.05). However, there was no significant difference in serum testosterone ([0.60±0.24] nmol/L vs [1.09±2.10] nmol/L) between the two groups (P>0.05). After 24 months of treatment, there were significant differences in in the FACT-4 total score ([97.95±7.54] vs [80.33±8.58]), renal-yang deficiency syndrome score ([14.64±5.15] vs [24.94±8.75]) between the treatment group and the control group (P<0.05). However, there was no significant difference in serum testosterone ( [0.73±1.01] nmol/L vs [0.59±0.25] nmol/L) between the two groups (P> 0.05). Better therapeutic results were showed in the treatment group in terms of total FACT-P score, physical situation score, social and family situation score, emotional state score, functional state score, additional score and renal-yang deficiency symptom score (P<0.05). Aft
目的:探讨内分泌治疗联合参芪丸治疗激素敏感性前列腺癌(HSPC)的临床疗效和安全性。方法:于2021年4月1日至2024年4月30日在湖南中医药大学第一附属医院和马阳苗族自治县中医医院诊断为HSPC和肾阳虚的患者80例,随机分为2组。对照组患者给予雄激素剥夺治疗(ADT)。治疗组患者在对照组的基础上口服参芪丸治疗。分析两组患者的基线资料。治疗36个月后,比较两组患者总生存期(OS)、前列腺特异性抗原(PSA)水平、PSA应答率、前列腺癌治疗功能评估量表(FACT-P)、中医循证评分、睾酮水平及安全性的差异。结果:本研究共纳入80例研究对象,其中治疗组42例,对照组38例。两组治疗前基线资料比较,差异无统计学意义(P < 0.05)。观察结束时,病程0 ~ 6个月患者亚组中,治疗组OS与对照组比较,差异有统计学意义(P0.05)。治疗6个月后,治疗组PSA50比例(98.1% vs 91.4%)、PSA90比例(92.9% vs 84.6%)、PSA下降比例(56.7% vs 33.8%)与对照组比较差异有统计学意义。治疗12个月后,治疗组FACT-4评分为(95.28±7.93)分,肾阳虚评分为(15.73±5.70)分,对照组为(85.46±10.12)分,肾阳虚评分为(18.20±4.27)分,差异有统计学意义(p < 0.05)。治疗24个月后,两组患者FACT-4总分([97.95±7.54]vs[80.33±8.58])、肾阳虚证评分([14.64±5.15]vs[24.94±8.75])比较,差异均有统计学意义(P < 0.05)。治疗组在FACT-P总分、身体状况评分、社会家庭状况评分、情绪状态评分、功能状态评分、附加评分、肾阳虚症状评分等方面均有较好的治疗效果(p)。结论:内分泌治疗联合参芪丸治疗HSPC患者安全有效,可降低HSPC患者死亡风险,且干预越早,患者总生存期越长。此外,该治疗方案可提高PSA应答率,改善患者生活质量,降低肾阳虚证评分,且无血清睾酮水平升高的风险。
{"title":"[Clinical efficacy of endocrinotherapy combined with Shenqi Pills on patients with hormone-sensitive prostate cancer].","authors":"Yu-Hong Xie, Gang Yi, Xiao-Wen Yi, Tong-Lin Sun, Qun-Fang Lin, Jun Zhou, Xin-Jun Luo, Fang-Zhi Fu, Biao Wang, Qin-Zheng Wang, Lie Zhang, Yang Yang, Rui-Song Gao, Qing Zhou","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The aim of this study is to explore the clinical efficacy and safety of endocrinotherapy combined with Shenqi Pills on hormone-sensitive prostate cancer (HSPC).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Eighty patients who were diagnosed with HSPC and renal-yang deficiency at the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine and the Hospital of Traditional Chinese Medicine of Mayang Miao Autonomous County from 1st April 2021 to 30th April 2024 were randomly divided into 2 groups. The patients in the control group were treated with androgen deprivation therapy (ADT). And the patients in treatment group were treated with Shenqi Pills orally on the basis of the control group. The baseline data of the two groups were analyzed. After 36 months of treatment, the differences between the two groups were compared in terms of overall survival (OS), prostate-specific antigen (PSA) level, PSA response rate, Functional Assessment Scale for Prostate Cancer Therapy (FACT-P), Chinese medicine evidence scores, testosterone level and safety.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 80 study subjects were included in this study, including 42 cases in the treatment group and 38 cases in the control group. There was no statistical difference in the baseline data between the two groups before treatment (P&gt;0.05). At the end of the observation period, a statistically significant difference in OS was found in the treatment group compared to the control group in the subgroup of patients with a disease duration ranged of 0-6 months (P&lt;0.05). There was no statistically significant difference in PSA levels in the treatment group at 3 months (P&gt;0.05). And the differences in the proportion of PSA50 (98.1% vs 91.4%), PSA90 (92.9% vs 84.6%) and the proportion of decrease in PSA (56.7% vs 33.8%) in the treatment group were found compared to those in the control group after 6 months of tre atment. After 12 months of treatment, the scores of FACT-4 and renal-yang deficiency in the treatment group were (95.28±7.93) and (15.73±5.70) respectively, compared to the scores in the control group ([85.46±10.12] and [18.20±4.27] (P&lt;0.05). However, there was no significant difference in serum testosterone ([0.60±0.24] nmol/L vs [1.09±2.10] nmol/L) between the two groups (P&gt;0.05). After 24 months of treatment, there were significant differences in in the FACT-4 total score ([97.95±7.54] vs [80.33±8.58]), renal-yang deficiency syndrome score ([14.64±5.15] vs [24.94±8.75]) between the treatment group and the control group (P&lt;0.05). However, there was no significant difference in serum testosterone ( [0.73±1.01] nmol/L vs [0.59±0.25] nmol/L) between the two groups (P&gt; 0.05). Better therapeutic results were showed in the treatment group in terms of total FACT-P score, physical situation score, social and family situation score, emotional state score, functional state score, additional score and renal-yang deficiency symptom score (P&lt;0.05). Aft","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 4","pages":"341-348"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144817676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Impact and action mechanisms of obesity on male reproductive function: An update]. 肥胖对男性生殖功能的影响及其作用机制:最新进展。
Q4 Medicine Pub Date : 2025-04-01
Ran Wei, Zhe-Tao Lang, Er-Hui Wang

The adverse effects of obesity on male reproductive function are mainly manifested as the abnormal development of the reproductive system, decrease of testosterone level, decline of sperm quality, and impact on the health of offspring, while its regulatory mechanism is far from being clarified. This paper expounds the influence of obesity on the male reproductive system in the aspects of population epidemiology and animal experiments, presents an overview on the action mechanisms of obesity from the perspectives of the hypothalamus-pituitary-testis axis, blood-testis barrier, inflammatory reaction, oxidative stress, testicular germ cell apoptosis, and impact of paternal obesity on the health of offspring, aiming to shed some light on the clinical treatment and prevention of obesity-related male reproductive dysfunction.

肥胖对男性生殖功能的不良影响主要表现为生殖系统发育异常、睾酮水平降低、精子质量下降、影响后代健康等,其调控机制尚不明确。本文从人群流行病学和动物实验等方面阐述了肥胖对男性生殖系统的影响,并从下丘脑-垂体-睾丸轴、血睾丸屏障、炎症反应、氧化应激、睾丸生殖细胞凋亡、父亲肥胖对后代健康的影响等方面综述了肥胖的作用机制。旨在为肥胖相关男性生殖功能障碍的临床治疗和预防提供一些启示。
{"title":"[Impact and action mechanisms of obesity on male reproductive function: An update].","authors":"Ran Wei, Zhe-Tao Lang, Er-Hui Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The adverse effects of obesity on male reproductive function are mainly manifested as the abnormal development of the reproductive system, decrease of testosterone level, decline of sperm quality, and impact on the health of offspring, while its regulatory mechanism is far from being clarified. This paper expounds the influence of obesity on the male reproductive system in the aspects of population epidemiology and animal experiments, presents an overview on the action mechanisms of obesity from the perspectives of the hypothalamus-pituitary-testis axis, blood-testis barrier, inflammatory reaction, oxidative stress, testicular germ cell apoptosis, and impact of paternal obesity on the health of offspring, aiming to shed some light on the clinical treatment and prevention of obesity-related male reproductive dysfunction.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 4","pages":"357-362"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144817684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Hypoandrogenism and the mode of cell death in the penile cavernosum tissue of male rats]. 雄性大鼠阴茎海绵体组织的低雄激素和细胞死亡模式。
Q4 Medicine Pub Date : 2025-04-01
Xin Zhao, Jing Li, Rui Jiang

Objective: To study the mode of cell death in the penile cavernosum tissue of male rats in the hypoandrogenic state.

Methods: We equally randomized 36 10-week-old SD male rats into six groups: 4-week sham-operation (4-wk SO), 8-week sham-operation (8-wk SO), 4-week castration (4-wk C), 8-week castration (8-wk C), 4-week castration + testosterone replacement (4-wk C+T), and 8-week castration + T replacement (8-wk C+T). The rats in the SO groups received incision of the scrotal skin with preservation of the testis and epididymis, those in the C groups underwent bilateral orchiectomy and epididymectomy, and those in the C+T groups were subcutaneously injected with T propionate at 3 mg/kg qd alt. We measured the ratio of maximum intracavernous pressure to mean arterial pressure (ICPmax/MAP), the concentration of serum T and the level of nitric oxide (NO), and determined the expressions of active caspase-1 and caspase-3 in the penile cavernosum of all the animals.

Results: The ICPmax/MAP ratio, serum T and NO levels and smooth muscle / collagen ratio were significantly lower in the C than in the SO and C+T groups (all P<0.05). The rats in the 4-wk C group, compared with those in the SO group, showed dramatic increases in the rates of endothelial cell pyroptosis ([15.31 ± 0.55]% vs [0.78 ± 0.53]%, P<0.01), endothelial cell apoptosis ([16.32 ± 0.97]% vs [0.88 ± 0.39]%, P<0.01), total cell pyroptosis ([9.67 ± 0.49]% vs [1.53 ± 0.24]%, P<0.01) and total cell apoptosis ([11.27 ± 0.94]% vs [1.68 ± 0.15]%, P<0.01) in the penile cavernous tissue, and so did those of the 8-wk C group in the rates of endothelial cell pyroptosis ([27.37 ± 0.65]% vs [1.02 ± 0.65]%, P<0.01), endothelial cell apoptosis ([24.27 ± 0.54]% vs [1.00 ± 0.63]%, P<0.01), total cell pyroptosis ([14.85 ± 0.55]% vs [1.72 ± 0.52]%, P<0.01) and total cell apoptosis ([15.92 ± 0.53]% vs [1.27 ± 0.31]%, P<0.01). The rats of the 8-wk C group exhibited an even more significant elevation than those of the 4-wk C group in the rates of endothelial cell pyroptosis ([27.37 ± 0.65]% vs [15.31 ± 0.55]%, P<0.05) and endothelial cell apoptosis ([24.27 ± 0.54]% vs [16.32 ± 0.97]%, P<0.05) .

Conclusion: Pyroptosis and apoptosis are the main modes of death of endothelial cells in the penile cavernosum of male rats after 4 weeks of castration and, with the progression of the disease, both increase with minimally expressed caspase-1 and caspase-3 in the smooth muscle cells. Endothelial cells and smooth muscle cells have different modes of death in different stages of hypoandrogenism.

目的:研究低雄激素状态下雄性大鼠阴茎海绵体组织细胞死亡模式。方法:将36只10周龄SD雄性大鼠随机分为6组:4周假手术(4周SO)、8周假手术(8周SO)、4周阉割(4周C)、8周阉割(8周C)、4周阉割+睾酮替代(4周C+T)、8周阉割+睾酮替代(8周C+T)。SO组大鼠行保留睾丸和附睾的阴囊皮肤切开,C组大鼠行双侧睾丸切除术和附睾切除术,C+T组大鼠皮下注射丙酸T,剂量为3 mg/kg qd。测定最大海绵内压与平均动脉压之比(ICPmax/MAP)、血清T浓度和一氧化氮(NO)水平。并测定了所有动物阴茎海绵体中活性caspase-1和caspase-3的表达。结果:C组的ICPmax/MAP比值、血清T、NO水平、平滑肌/胶原比值均显著低于SO组和C+T组(均为p组)。结论:雄性大鼠去势4周后阴茎海绵体内皮细胞的主要死亡方式为凋亡和凋亡,且随疾病进展,两者均升高,平滑肌细胞中caspase-1和caspase-3表达最低。内皮细胞和平滑肌细胞在雄激素减退症的不同阶段有不同的死亡方式。
{"title":"[Hypoandrogenism and the mode of cell death in the penile cavernosum tissue of male rats].","authors":"Xin Zhao, Jing Li, Rui Jiang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To study the mode of cell death in the penile cavernosum tissue of male rats in the hypoandrogenic state.</p><p><strong>Methods: </strong>We equally randomized 36 10-week-old SD male rats into six groups: 4-week sham-operation (4-wk SO), 8-week sham-operation (8-wk SO), 4-week castration (4-wk C), 8-week castration (8-wk C), 4-week castration + testosterone replacement (4-wk C+T), and 8-week castration + T replacement (8-wk C+T). The rats in the SO groups received incision of the scrotal skin with preservation of the testis and epididymis, those in the C groups underwent bilateral orchiectomy and epididymectomy, and those in the C+T groups were subcutaneously injected with T propionate at 3 mg/kg qd alt. We measured the ratio of maximum intracavernous pressure to mean arterial pressure (ICPmax/MAP), the concentration of serum T and the level of nitric oxide (NO), and determined the expressions of active caspase-1 and caspase-3 in the penile cavernosum of all the animals.</p><p><strong>Results: </strong>The ICPmax/MAP ratio, serum T and NO levels and smooth muscle / collagen ratio were significantly lower in the C than in the SO and C+T groups (all P<0.05). The rats in the 4-wk C group, compared with those in the SO group, showed dramatic increases in the rates of endothelial cell pyroptosis ([15.31 ± 0.55]% vs [0.78 ± 0.53]%, P<0.01), endothelial cell apoptosis ([16.32 ± 0.97]% vs [0.88 ± 0.39]%, P<0.01), total cell pyroptosis ([9.67 ± 0.49]% vs [1.53 ± 0.24]%, P<0.01) and total cell apoptosis ([11.27 ± 0.94]% vs [1.68 ± 0.15]%, P<0.01) in the penile cavernous tissue, and so did those of the 8-wk C group in the rates of endothelial cell pyroptosis ([27.37 ± 0.65]% vs [1.02 ± 0.65]%, P<0.01), endothelial cell apoptosis ([24.27 ± 0.54]% vs [1.00 ± 0.63]%, P<0.01), total cell pyroptosis ([14.85 ± 0.55]% vs [1.72 ± 0.52]%, P<0.01) and total cell apoptosis ([15.92 ± 0.53]% vs [1.27 ± 0.31]%, P<0.01). The rats of the 8-wk C group exhibited an even more significant elevation than those of the 4-wk C group in the rates of endothelial cell pyroptosis ([27.37 ± 0.65]% vs [15.31 ± 0.55]%, P<0.05) and endothelial cell apoptosis ([24.27 ± 0.54]% vs [16.32 ± 0.97]%, P<0.05) .</p><p><strong>Conclusion: </strong>Pyroptosis and apoptosis are the main modes of death of endothelial cells in the penile cavernosum of male rats after 4 weeks of castration and, with the progression of the disease, both increase with minimally expressed caspase-1 and caspase-3 in the smooth muscle cells. Endothelial cells and smooth muscle cells have different modes of death in different stages of hypoandrogenism.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 4","pages":"291-299"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144817683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Influencing factors of positive surgical margins after radical resection of prostate cancer]. [影响前列腺癌根治术后手术切缘阳性的因素]。
Q4 Medicine Pub Date : 2025-04-01
Chang-Jie Shi, Zhi-Jian Ren, Ying Zhang, Ding Wu, Bo Fang, Xiu-Quan Shi, Wen Cheng, Dian Fu, Xiao-Feng Xu

Objective: To investigate the influencing factors of pathological positive surgical margins (PSM) after radical resection of prostate cancer.

Methods: The clinical data of 407 patients who underwent radical resection of prostate cancer in our hospital from 2011 to 2020 were retrospectively analyzed. And the patients were divided into two groups according to postoperative pathological results. Single factor analysis was used to evaluate the differences in postoperative Gleason score, preoperative total prostate-specific antigen (tPSA), preoperative serum free prostate-specific antigen to preoperative tPSA ratio (fPSA/ tPSA), clinical stage, postoperative pathological stage, operation method, age, body mass index (BMI), diameter and volume of prostate tumor. Multivariate logistic regression was used to determine the independent risk factor of PSM.

Results: Among 407 patients with prostate cancer, 179 cases (43.98%) were positive. Univariate analysis showed that there were significant differences in postoperative Gleason score, preoperative tPSA, clinical stage and postoperative pathological stage between the two groups (P<0.05). And Gleason score, preoperative tPSA and pathologic stage were independent risk factors for PSM.

Conclusion: There are relationships between PSM and postoperative Gleason score, tPSA, clinical T stage, postoperative pathologic pT stage. Among them, postoperative Gleason score (Gleason=7 points, Gleason≥8 points), preoperative total prostate-specific antigen (tPSA > 20 μg/L), and postoperative pathologic pT stage (pT3a, pT3b) were independent risk factors for positive pathological margins of prostate cancer.

目的:探讨前列腺癌根治术后病理阳性切缘(PSM)的影响因素。方法:回顾性分析2011 ~ 2020年我院407例前列腺癌根治术患者的临床资料。根据术后病理结果将患者分为两组。采用单因素分析评价术后Gleason评分、术前总前列腺特异性抗原(tPSA)、术前血清游离前列腺特异性抗原与术前tPSA之比(fPSA/ tPSA)、临床分期、术后病理分期、手术方式、年龄、体重指数(BMI)、前列腺肿瘤直径、体积的差异。采用多因素logistic回归确定PSM的独立危险因素。结果:407例前列腺癌患者中,阳性179例(43.98%)。单因素分析显示,两组患者术后Gleason评分、术前tPSA、临床分期、术后病理分期差异均有统计学意义(p)。结论:PSM与术后Gleason评分、tPSA、临床T分期、术后病理pT分期存在相关性。其中,术后Gleason评分(Gleason=7分,Gleason≥8分)、术前总前列腺特异性抗原(tPSA > 20 μg/L)、术后病理pT分期(pT3a、pT3b)是前列腺癌病理边缘阳性的独立危险因素。
{"title":"[Influencing factors of positive surgical margins after radical resection of prostate cancer].","authors":"Chang-Jie Shi, Zhi-Jian Ren, Ying Zhang, Ding Wu, Bo Fang, Xiu-Quan Shi, Wen Cheng, Dian Fu, Xiao-Feng Xu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the influencing factors of pathological positive surgical margins (PSM) after radical resection of prostate cancer.</p><p><strong>Methods: </strong>The clinical data of 407 patients who underwent radical resection of prostate cancer in our hospital from 2011 to 2020 were retrospectively analyzed. And the patients were divided into two groups according to postoperative pathological results. Single factor analysis was used to evaluate the differences in postoperative Gleason score, preoperative total prostate-specific antigen (tPSA), preoperative serum free prostate-specific antigen to preoperative tPSA ratio (fPSA/ tPSA), clinical stage, postoperative pathological stage, operation method, age, body mass index (BMI), diameter and volume of prostate tumor. Multivariate logistic regression was used to determine the independent risk factor of PSM.</p><p><strong>Results: </strong>Among 407 patients with prostate cancer, 179 cases (43.98%) were positive. Univariate analysis showed that there were significant differences in postoperative Gleason score, preoperative tPSA, clinical stage and postoperative pathological stage between the two groups (P<0.05). And Gleason score, preoperative tPSA and pathologic stage were independent risk factors for PSM.</p><p><strong>Conclusion: </strong>There are relationships between PSM and postoperative Gleason score, tPSA, clinical T stage, postoperative pathologic pT stage. Among them, postoperative Gleason score (Gleason=7 points, Gleason≥8 points), preoperative total prostate-specific antigen (tPSA > 20 μg/L), and postoperative pathologic pT stage (pT3a, pT3b) were independent risk factors for positive pathological margins of prostate cancer.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 4","pages":"328-332"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144817685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Efficacy and safety of denosumab in the treatment of prostate cancer with bone metastases: A systematic review and meta-analysis]. denosumab治疗前列腺癌骨转移的疗效和安全性:一项系统综述和荟萃分析。
Q4 Medicine Pub Date : 2025-04-01
Li Yang, Bo Fang, Can-Qin He, Xu-Xin Zhan, You-Ping Xiao, Xiao-Jun Qin, Qiang Lou, Xue-Jun Shang

Objective: To evaluate the efficacy and safety of denosumab in the treatment of prostate cancer with bone metastases.

Methods: Relevant studies were retrieved from PubMed, EMBASE, Cochrane, Web of Science, Sinomed , CNKI and Wanfang databases. The Cochrane risk-of-bias assessment tool was used to evaluate the quality of included studies, and relevant data were extracted. meta-analysis was performed using RevMan 5.4 and RStudio software, and forest plots were generated.

Results: Six randomized controlled trials (RCTs) were included. Compared with the control group, denosumab significantly reduced the risk of skeletal-related events (HR=0.78, 95% CI: 0.62-0.93). In terms of safety, denosumab did not increase the risk of total adverse events, severe adverse events and the adverse events higher than CTC grade 3.

Conclusion: Denosumab can delay the time to first skeletal-related event with good safety. However, due to the limitations of this study, further high-quality, large-sample, multicenter RCTs are needed to confirm these findings.

目的:评价地诺单抗治疗前列腺癌骨转移的疗效和安全性。方法:检索PubMed、EMBASE、Cochrane、Web of Science、Sinomed、CNKI、万方等数据库的相关研究。采用Cochrane偏倚风险评估工具评价纳入研究的质量,并提取相关资料。采用RevMan 5.4和RStudio软件进行meta分析,生成森林样地。结果:纳入6项随机对照试验(RCTs)。与对照组相比,denosumab显著降低了骨骼相关事件的风险(HR=0.78, 95% CI: 0.62-0.93)。在安全性方面,denosumab没有增加总不良事件、严重不良事件和高于CTC 3级的不良事件的风险。结论:Denosumab可延迟患者发生首次骨骼相关事件的时间,且安全性较好。然而,由于本研究的局限性,需要进一步的高质量、大样本、多中心随机对照试验来证实这些发现。
{"title":"[Efficacy and safety of denosumab in the treatment of prostate cancer with bone metastases: A systematic review and meta-analysis].","authors":"Li Yang, Bo Fang, Can-Qin He, Xu-Xin Zhan, You-Ping Xiao, Xiao-Jun Qin, Qiang Lou, Xue-Jun Shang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the efficacy and safety of denosumab in the treatment of prostate cancer with bone metastases.</p><p><strong>Methods: </strong>Relevant studies were retrieved from PubMed, EMBASE, Cochrane, Web of Science, Sinomed , CNKI and Wanfang databases. The Cochrane risk-of-bias assessment tool was used to evaluate the quality of included studies, and relevant data were extracted. meta-analysis was performed using RevMan 5.4 and RStudio software, and forest plots were generated.</p><p><strong>Results: </strong>Six randomized controlled trials (RCTs) were included. Compared with the control group, denosumab significantly reduced the risk of skeletal-related events (HR=0.78, 95% CI: 0.62-0.93). In terms of safety, denosumab did not increase the risk of total adverse events, severe adverse events and the adverse events higher than CTC grade 3.</p><p><strong>Conclusion: </strong>Denosumab can delay the time to first skeletal-related event with good safety. However, due to the limitations of this study, further high-quality, large-sample, multicenter RCTs are needed to confirm these findings.</p>","PeriodicalId":24012,"journal":{"name":"中华男科学杂志","volume":"31 4","pages":"349-356"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144817680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华男科学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1